메뉴 건너뛰기




Volumn 21, Issue 9, 2015, Pages 1121-1130

TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis

(70)  Trentini, Alessandro a   Manfrinato, Maria C a   Castellazzi, Massimiliano a   Tamborino, Carmine a   Roversi, Gloria a   Volta, Carlo A a   Baldi, Eleonora b   Tola, Maria R b   Granieri, Enrico a   Dallocchio, Franco a   Bellini, Tiziana a   Fainardi, Enrico b   Casetta, I a   Rizzo, R a   Rotola, A a   Di Luca, D a   Seraceni, S a   Contini, C a   Sabbioni, S a   Negrini, M a   more..


Author keywords

Biomarkers; Enzymes; Inflammation; Isoforms; Magnetic resonance imaging; Matrix metalloproteinase 9; Multiple sclerosis; Serum levels; TIMP 1 resistance

Indexed keywords

GADOLINIUM; GELATINASE B; ISOPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; ISOENZYME; MMP9 PROTEIN, HUMAN; TIMP1 PROTEIN, HUMAN;

EID: 84985931064     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514560925     Document Type: Article
Times cited : (21)

References (32)
  • 1
    • 67349216357 scopus 로고    scopus 로고
    • Autoimmune T-cell responses in the central nervous system
    • Goverman J. Autoimmune T-cell responses in the central nervous system. Nat Rev Immunol 2009; 9: 393-407.
    • (2009) Nat Rev Immunol , vol.9 , pp. 393-407
    • Goverman, J.1
  • 2
    • 65649096159 scopus 로고    scopus 로고
    • Localizing central nervous system immune surveillance: Meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis
    • Kivisäkk P, Imitola J, Rasmussen S, et al. Localizing central nervous system immune surveillance: Meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann Neurol 2009; 65: 457-469.
    • (2009) Ann Neurol , vol.65 , pp. 457-469
    • Kivisäkk, P.1    Imitola, J.2    Rasmussen, S.3
  • 3
    • 0342906187 scopus 로고    scopus 로고
    • Heterogeneity of multiple sclerosis lesions: Implications for pathogenesis of demyelination
    • Lucchinetti C, Brück W, Prisi J, et al. Heterogeneity of multiple sclerosis lesions: Implications for pathogenesis of demyelination. Ann Neurol 2000; 47: 707-717.
    • (2000) Ann Neurol , vol.47 , pp. 707-717
    • Lucchinetti, C.1    Brück, W.2    Prisi, J.3
  • 4
    • 0344961161 scopus 로고    scopus 로고
    • Blood-brain Barrier disruption in multiple sclerosis
    • Minagar A and Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler 2003; 9: 540-549.
    • (2003) Mult Scler , vol.9 , pp. 540-549
    • Minagar, A.1    Alexander, J.S.2
  • 5
    • 84859540194 scopus 로고    scopus 로고
    • Multiple sclerosis
    • Miller E. Multiple sclerosis. Adv Exp Med Biol 2012; 724: 222-238.
    • (2012) Adv Exp Med Biol , vol.724 , pp. 222-238
    • Miller, E.1
  • 6
    • 84884592784 scopus 로고    scopus 로고
    • Pathophysiology of the brain extracellular matrix: A new target for remyelination
    • Lau LW, Cua R, Keough MB, et al. Pathophysiology of the brain extracellular matrix: A new target for remyelination. Nat Rev Neurosci 2013; 14: 722-729.
    • (2013) Nat Rev Neurosci , vol.14 , pp. 722-729
    • Lau, L.W.1    Cua, R.2    Keough, M.B.3
  • 7
    • 84855881970 scopus 로고    scopus 로고
    • Serum levels of matrix metalloproteinases: Implications in clinical neurology
    • Romi F, Helgeland G and Gilhus NE. Serum levels of matrix metalloproteinases: Implications in clinical neurology. Eur Neurol 2012; 67: 121-128.
    • (2012) Eur Neurol , vol.67 , pp. 121-128
    • Romi, F.1    Helgeland, G.2    Gilhus, N.E.3
  • 8
    • 0037693895 scopus 로고    scopus 로고
    • Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function and biochemistry
    • Visse R and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function and biochemistry. Circ Res 2003; 92: 827-839.
    • (2003) Circ Res , vol.92 , pp. 827-839
    • Visse, R.1    Nagase, H.2
  • 9
    • 58249126857 scopus 로고    scopus 로고
    • Matrix metalloproteinases and their multiple roles in neurodegenerative diseases
    • Rosenberg GA Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009; 8: 205-216.
    • (2009) Lancet Neurol , vol.8 , pp. 205-216
    • Rosenberg, G.A.1
  • 10
    • 36849094431 scopus 로고    scopus 로고
    • Matrix metalloproteinases as modulators of inflammation
    • Manicone AM and McGuire JK. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 2008; 19: 34-41.
    • (2008) Semin Cell Dev Biol , vol.19 , pp. 34-41
    • Manicone, A.M.1    McGuire, J.K.2
  • 11
    • 0031798063 scopus 로고    scopus 로고
    • Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis
    • Leppert D, Ford J, Stabler G, et al. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 1998; 121: 2327-2334.
    • (1998) Brain , vol.121 , pp. 2327-2334
    • Leppert, D.1    Ford, J.2    Stabler, G.3
  • 12
    • 0032948343 scopus 로고    scopus 로고
    • Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study
    • Lee MA, Palace J, Stabler G, et al. Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. Brain 1999; 122: 191-197.
    • (1999) Brain , vol.122 , pp. 191-197
    • Lee, M.A.1    Palace, J.2    Stabler, G.3
  • 13
    • 0032693982 scopus 로고    scopus 로고
    • Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis
    • Waubant E, Goodkin DE, Gee L, et al. Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology 1999; 53: 1397-1401.
    • (1999) Neurology , vol.53 , pp. 1397-1401
    • Waubant, E.1    Goodkin, D.E.2    Gee, L.3
  • 14
    • 0033622321 scopus 로고    scopus 로고
    • CCRΔ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis
    • Sellebjerg F, Madsen HO, Jensen CV, et al. CCRΔ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis. J Neuroimmunol 2000; 102: 98-106.
    • (2000) J Neuroimmunol , vol.102 , pp. 98-106
    • Sellebjerg, F.1    Madsen, H.O.2    Jensen, C.V.3
  • 15
    • 0035989120 scopus 로고    scopus 로고
    • Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: Implication for pathogenesis
    • Liuzzi GM, Trojano M, Fanelli M, et al. Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: Implication for pathogenesis. Mult Scler 2002; 8: 222-228.
    • (2002) Mult Scler , vol.8 , pp. 222-228
    • Liuzzi, G.M.1    Trojano, M.2    Fanelli, M.3
  • 16
    • 0037333750 scopus 로고    scopus 로고
    • Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes
    • Avolio C, Ruggieri M, Giuliani F, et al. Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes. J Neuroimmunol 2003; 136: 46-53.
    • (2003) J Neuroimmunol , vol.136 , pp. 46-53
    • Avolio, C.1    Ruggieri, M.2    Giuliani, F.3
  • 17
    • 61849164425 scopus 로고    scopus 로고
    • Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis
    • Benesová Y, Vasku A, Novotná H, et al. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis. Mult Scler 2009; 15: 316-322.
    • (2009) Mult Scler , vol.15 , pp. 316-322
    • Benesová, Y.1    Vasku, A.2    Novotná, H.3
  • 18
    • 77955022345 scopus 로고    scopus 로고
    • Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b
    • Alexander JS, Harris MK, Wells SR, et al. Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b. Mult Scler 2010; 16: 801-809.
    • (2010) Mult Scler , vol.16 , pp. 801-809
    • Alexander, J.S.1    Harris, M.K.2    Wells, S.R.3
  • 19
    • 33744811943 scopus 로고    scopus 로고
    • Cerebrospinal fluid and serum levels, and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis
    • Fainardi E, Castellazzi M, Bellini T, et al. Cerebrospinal fluid and serum levels, and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Mult Scler 2006; 12: 294-301.
    • (2006) Mult Scler , vol.12 , pp. 294-301
    • Fainardi, E.1    Castellazzi, M.2    Bellini, T.3
  • 20
    • 84860463028 scopus 로고    scopus 로고
    • Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms
    • Bellini T, Trentini A, Manfrinato MC, et al. Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms. J Biochem 2012; 151: 493-499.
    • (2012) J Biochem , vol.151 , pp. 493-499
    • Bellini, T.1    Trentini, A.2    Manfrinato, M.C.3
  • 21
    • 0026795140 scopus 로고
    • Matrix metalloproteinase 9 (92-kDa gelatinase/Type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties
    • Okada Y, Gonoji Y, Naka K, et al. Matrix metalloproteinase 9 (92-kDa gelatinase/Type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 1992; 267: 21712-21719.
    • (1992) J Biol Chem , vol.267 , pp. 21712-21719
    • Okada, Y.1    Gonoji, Y.2    Naka, K.3
  • 22
    • 0026660964 scopus 로고
    • Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9
    • Ogata Y, Enghild JJ and Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 1992; 267: 3581-3584.
    • (1992) J Biol Chem , vol.267 , pp. 3581-3584
    • Ogata, Y.1    Enghild, J.J.2    Nagase, H.3
  • 23
    • 38049136866 scopus 로고    scopus 로고
    • A biochemical model of matrix metalloproteinase 9 activation and inhibition
    • Vempati P, Karagiannis ED and Popel AS. A biochemical model of matrix metalloproteinase 9 activation and inhibition. J Biol Chem 2007; 282: 37585-37596.
    • (2007) J Biol Chem , vol.282 , pp. 37585-37596
    • Vempati, P.1    Karagiannis, E.D.2    Popel, A.S.3
  • 24
    • 84893700542 scopus 로고    scopus 로고
    • Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants
    • Rossano R, Larocca M, Riviello L, et al. Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants. J Cell Mol Med 2014; 18: 242-252.
    • (2014) J Cell Mol Med , vol.18 , pp. 242-252
    • Rossano, R.1    Larocca, M.2    Riviello, L.3
  • 25
    • 0034955141 scopus 로고    scopus 로고
    • Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
    • McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121-127.
    • (2001) Ann Neurol , vol.50 , pp. 121-127
    • McDonald, W.I.1    Compston, A.2    Edan, G.3
  • 26
    • 0029913882 scopus 로고    scopus 로고
    • Defining the clinical course of multiple sclerosis: Results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis
    • Lublin FD and Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-911.
    • (1996) Neurology , vol.46 , pp. 907-911
    • Lublin, F.D.1    Reingold, S.C.2
  • 27
    • 0020686503 scopus 로고
    • New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
    • Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
    • (1983) Ann Neurol , vol.13 , pp. 227-231
    • Poser, C.M.1    Paty, D.W.2    Scheinberg, L.3
  • 28
    • 0027381828 scopus 로고
    • Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis
    • Miller DH, Barkhof F and Nauta JJP. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 1993; 116: 1077-1094.
    • (1993) Brain , vol.116 , pp. 1077-1094
    • Miller, D.H.1    Barkhof, F.2    Nauta, J.J.P.3
  • 29
    • 80054933935 scopus 로고    scopus 로고
    • Detection of functional matrix metalloproteinases by zymography
    • Hu X and Beeton C. Detection of functional matrix metalloproteinases by zymography. J Vis Exp 2010: 1-4.
    • J Vis Exp , vol.2010 , pp. 1-4
    • Hu, X.1    Beeton, C.2
  • 30
    • 84899793854 scopus 로고    scopus 로고
    • Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain Barrier
    • Shimizu F, Tasaki A, Sano Y, et al. Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier. PLoS One 2014; 9: e92872.
    • (2014) PLoS One , vol.9
    • Shimizu, F.1    Tasaki, A.2    Sano, Y.3
  • 31
    • 32344445287 scopus 로고    scopus 로고
    • Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis
    • Kanesaka T, Mori M, Hattori T, et al. Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2006; 77: 185-188.
    • (2006) J Neurol Neurosurg Psychiatry , vol.77 , pp. 185-188
    • Kanesaka, T.1    Mori, M.2    Hattori, T.3
  • 32
    • 0034842248 scopus 로고    scopus 로고
    • The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal-appearing white matter of multiple sclerosis
    • Lindberg RL, De Groot CJ, Montagne L, et al. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal-appearing white matter of multiple sclerosis. Brain 2001; 124: 1743-1753.
    • (2001) Brain , vol.124 , pp. 1743-1753
    • Lindberg, R.L.1    De Groot, C.J.2    Montagne, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.